China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

China provides 500m COVID-19 vaccine doses to intl community
2021-07-12
BEIJING — China has provided more than 100 countries and international organizations with 500 million doses of COVID-19 vaccines and concentrates, accounting for one-sixth of the current global COVID-19 vaccine production, a Foreign Ministry official told Xinhua on July 9.
Guo Xuejun, deputy director-general of the department of international economic affairs at the Foreign Ministry, said during an interview with Xinhua that China has also actively supported other developing countries in producing vaccines to expand the global vaccine capacity.
China has always accommodated domestic and foreign needs for COVID-19 vaccines, said Guo, adding that China opposes vaccine nationalism.
With the help of the Chinese government, Chinese vaccine enterprises have carried out joint vaccine production in countries including the UAE, Indonesia, Malaysia, Egypt, Brazil, Turkey, Pakistan and Mexico, with production exceeding 200 million doses, Guo said.
Among the 140 countries that have signed Belt and Road cooperation documents with China, 84 countries have proposed introducing Chinese vaccines in the first half of this year, said Guo, adding that China has made a positive response to all these countries and provided vaccines…

POLIO Public Health Emergency of International Concern (PHEIC)

Emergencies

POLIO
Public Health Emergency of International Concern (PHEIC)

Polio this week as of 14 July 2021

Summary of new WPV and cVDPV viruses this week (AFP cases and ES positives):
:: Nigeria: one cVDPV2 case and two cVDPV2 positive environmental samples
:: Senegal: two cVDPV2 cases and two cVDPV2 positive environmental samples
:: Sierra Leone: one cVDPV2 positive environmental sample
:: Somalia: one cVDPV2 positive environmental sample
:: Tajikistan: one cVDPV2 case

 

::::::
::::::

WHO/OCHA Emergencies

 

Editor’s Note:
WHO has apparently reorganized and fundamentally shifted how it judges and tracks “emergencies”. We found no announcement of descriptive information to share and present the webpage structure as encountered below. Obviously, the dates associated with some of these emergencies suggest that this is an archival platform as well as a current emergencies resource.

Health emergencies list – WHO
“The health emergencies list details the disease outbreaks, disasters and humanitarian crises where WHO plays an essential role in supporting countries to respond to and recover from emergencies with public health consequences.”

Crisis in Tigray, Ethiopia
:: Ethiopia – Tigray Region Humanitarian Update Situation Report Last updated: 9 Jul 2021

 

Ebola outbreak, Democratic Republic of the Congo, 2021
[Last apparent update: 3 May 2021]

Ebola outbreak outbreak, N’Zerekore, Guinea, 2021 [Last apparent update: 3 May 2021]

Coronavirus disease (COVID-19) pandemic [Last apparent update 16 July 2021; See COVID above]

Ebola outbreak, Equateur Province, Democratic Republic of the Congo, 2020 [Last apparent update: 1 June 2021]

Ebola outbreak, North Kivu, Ituri, Democratic Republic of the Congo, 2018 – 2020 [Last apparent update: 3 May 2021]

Ebola outbreak, Democratic Republic of the Congo, 2018 [Last apparent update: 24 July 2018]

Yemen crisis [Last apparent update: 12 February 2021]

Syria crisis [Last apparent update: 18 June 2021]

Somalia crisis [Last apparent update: 24 March 2018]

Nigeria crisis [Last apparent update: 9 May 2018]

Ebola outbreak, Democratic Republic of the Congo, 2017 [Last apparent update: 3 May 2021]

Zika virus disease outbreak, 2015-2016 [Last apparent update: 24 Jan 2020]

Ebola outbreak: West Africa, 2014-2016 [Last apparent update: 3 May 2021]

Iraq crisis [Last apparent update: 9 Jan 2008]

South Sudan crisis [Last apparent update: 23 Sep 2020]

Avian influenza A (H7N9) virus outbreak [Last apparent update: 21 May 2021]

Middle East respiratory syndrome (MERS-CoV) outbreak [Last apparent update: 8 July 2019]

Influenza A (H1N1) virus, 2009-2010 pandemic [Last apparent update: 10 Aug 2010]

 

::::::

UN OCHA – Current Emergencies
Current Corporate Emergencies
Northern Ethiopia
[No new digest content identified]

 

::::::
::::::

MMWR News Synopsis Friday, July 16, 2021

MMWR News Synopsis Friday, July 16, 2021
:: COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 15, 2021
:: COVID-19 Vaccine Administration, by Race and Ethnicity — North Carolina, December 14, 2020–April 6, 2021
:: Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents — United States, April 15–23, 2021 (Early Release July 9, 2021)
:: SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility — Oklahoma, April–May 2021 (Early Release July 9, 2021)

China CDC http://www.chinacdc.cn/en/

China CDC http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China [to 17 Jul 2021]
http://en.nhc.gov.cn/
News
July 17: Daily briefing on novel coronavirus cases in China
On July 16, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 30 new cases of confirmed infections.

China provides 500m COVID-19 vaccine doses to intl community
2021-07-12
BEIJING — China has provided more than 100 countries and international organizations with 500 million doses of COVID-19 vaccines and concentrates, accounting for one-sixth of the current global COVID-19 vaccine production, a Foreign Ministry official told Xinhua on July 9.
Guo Xuejun, deputy director-general of the department of international economic affairs at the Foreign Ministry, said during an interview with Xinhua that China has also actively supported other developing countries in producing vaccines to expand the global vaccine capacity.
China has always accommodated domestic and foreign needs for COVID-19 vaccines, said Guo, adding that China opposes vaccine nationalism.
With the help of the Chinese government, Chinese vaccine enterprises have carried out joint vaccine production in countries including the UAE, Indonesia, Malaysia, Egypt, Brazil, Turkey, Pakistan and Mexico, with production exceeding 200 million doses, Guo said.
Among the 140 countries that have signed Belt and Road cooperation documents with China, 84 countries have proposed introducing Chinese vaccines in the first half of this year, said Guo, adding that China has made a positive response to all these countries and provided vaccines…

National Medical Products Administration – PRC [to 17 Jul 2021]
http://english.nmpa.gov.cn/news.html
News
Vaccination push extends to teenagers
2021-07-16
Some local governments in China are planning to administer COVID-19 vaccines to teenagers as the country pushes ahead with its mass immunization drive, with over 1.4 billion doses already administered.
The health commission in the Guangxi Zhuang autonomous region said on Tuesday that it will focus on vaccinating those aged 12 to 17 and the elderly in the second half of this year…

Over 1.4b doses of COVID-19 vaccines administered in China
2021-07-15
Over 1.4 billion doses of COVID-19 vaccines have been administered in China as of Tuesday, as the country continues to ramp up its inoculation drive, the National Health Commission said on July 14.

CCDC Weekly – Weekly Reports: Current Volume (3)
2021-07-16 / No. 29
PDF of this issue
Preplanned Studies: Prevalence of Antimicrobial Resistant of Vibrio parahaemolyticus Isolated from Diarrheal Patients — Six PLADs, China, 2016−2020

Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

 

Paul G. Allen Frontiers Group [to 17 Jul 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 17 Jul 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
No new digest content identified.

 

BMGF – Gates Foundation [to 17 Jul 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 17 Jul 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 17 Jul 2021]
https://carb-x.org/
News
No new digest content identified.

 

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 17 Jul 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – July 2021 is now posted here

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 17 Jul 2021]
http://cepi.net/
Latest News
CEPI launches COVAX Marketplace to match buyers and sellers of critical manufacturing supplies and speed up global access to COVID-19 vaccines through COVAX
15 Jul 2021
[See COVAX above for detail]

 

CIOMS – COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES [to 17 Jul 2021]
https://cioms.ch/
News; Publications
No new digest content identified.

 

DARPA – Defense Advanced Research Projects Agency [to 17 Jul 2021
https://www.darpa.mil/news
News
No new digest content identified.

 

Duke Global Health Innovation Center [to 17 Jul 2021]
https://dukeghic.org/
No new digest content identified.

 

EDCTP [to 17 Jul 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
16 July 2021
Biofabri and IAVI announce partnership to advance MTBVAC into efficacy trials
Biofabri and IAVI have announced their intention to partner on efficacy trials of the tuberculosis (TB) vaccine candidate MTBVAC. This highly promising vaccine candidate has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB disease in adolescents and adults…

 

Emory Vaccine Center [to 17 Jul 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Vaccine Initiative [to 17 Jul 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified

 

FDA [to 17 Jul 2021]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
July 16, 2021 – Coronavirus (COVID-19) Update: July 16, 2021
Today, as Pfizer has announcedExternal Link Disclaimer, the FDA has formally accepted the company’s Biologics License Application (BLA) requesting licensure (approval) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older and has granted the application priority review. Currently, the vaccine is authorized for emergency use to prevent COVID-19 in individuals ages 12 and older. The Prescription Drug User Fee (PDUFA) Goal Date of January 2022 reflects the PDUFA deadline for Priority Review and does not mean approval will not happen before that time. Quite to the contrary, the review of this BLA has been ongoing, is among the highest priorities of the agency, and the agency intends to complete the review far in advance of the PDUFA Goal Date.

July 13, 2021 – Coronavirus (COVID-19) Update: July 13, 2021
Today, the FDA is announcing revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination.

 

Fondation Merieux [to 17 Jul 2021]
http://www.fondation-merieux.org/
News, Events
Announcement
IRD and the Mérieux Foundation renew their agreement and strengthen their cooperation on healthcare and research relating to infectious diseases
July 7, 2021, Global

 

Gavi [to 17 Jul 2021]
https://www.gavi.org/
News Releases
16 July 2021
US-donated vaccine deliveries to Africa set to begin, with first deliveries planned to Burkina Faso, Djibouti, and Ethiopia
[See COVAX above for detail]

12 July 2021
Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX
[See COVAX above for detail]

 

GHIT Fund [to 17 Jul 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
July 15, 2021
GHIT Fund Announces New Investment: 97.4 Million Yen to Identify Novel Dual-Acting Bactericidal Drug Targets Against Mycobacterium Tuberculosis

 

Global Fund [to 17 Jul 2021]
https://www.theglobalfund.org/en/news/
News & Stories
News
Global Fund Applauds Switzerland’s Leadership in The Global Fight Against COVID-19
14 July 2021
The Global Fund to Fight AIDS, Tuberculosis and Malaria praised the decision by the Swiss Federal Council to make available CHF300 million to the Access to COVID-19 Tools (ACT) Accelerator – a ground-breaking global collaboration of leading public health agencies to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, while strengthening health systems. This new commitment follows an earlier announcement made in 2020 by the Swiss Federal Council of a CHF400 million contribution.

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 17 Jul 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.

 

Hilleman Laboratories [to 17 Jul 2021]
http://www.hillemanlabs.org/
Website reports “under maintenance” at inquiry

 

Human Vaccines Project [to 17 Jul 2021]
http://www.humanvaccinesproject.org/
News
News webpage not responding at inquiry

 

IAVI [to 17 Jul 2021]
https://www.iavi.org/newsroom
Latest News
PRESS RELEASES
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials
TB kills 1.4 million people a year, an infectious disease toll only recently surpassed by COVID-19.
COVID-19 has reversed years of progress in TB response, costing additional lives and adding to the urgency of the global TB problem.
MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB disease in adolescents and adults.
PORRIÑO, SPAIN, and NEW YORK, U.S. — JULY 14, 2021 — Spanish biopharmaceutical company Biofabri and IAVI today announced their intention to partner on efficacy trials of the tuberculosis (TB) vaccine candidate MTBVAC.
was in-licensed and is being manufactured and developed by Biofabri, a subsidiary of the Zendal Group, in collaboration with University of Zaragoza, IAVI, and Europe-based Tuberculosis Vaccine Initiative (TBVI)…

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

ICRC [to 17 Jul 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
Humanitarian space – or spaces – must be protected, without exception

Written statement by the International Committee of the Red Cross to the UN Security Council Briefing: Protection of Civilians in Armed Conflict: Preserving Humanitarian Space.
16-07-2021 | Statement

Ethiopia: Communities in Tigray hit hard by growing food and fuel prices
ICRC operational updated following the ongoing crisis that began with fighting nine months ago in the Tigray region.
15-07-2021 | News release

The World Bank, ICRC and UNICEF launch a report on joining forces in humanitarian and development collaboration to improve responses to protracted crises
Water and sanitation are priorities in both humanitarian and development work, but evidence shows that a lack of collaboration in conflict and violence-affected contexts between humanitarian and development support agencies is increasing costs, reduc
09-07-2021 | News release

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
COVAX begins vaccine rollout amid global supply challenges
09 Jul 2021
Camel riders traverse Northern Kenya to spread the word about COVID-19 vaccines. Planes bearing half a million vaccines touch down in Manila. Mongolian villagers gather in a health centre waiting room in Batsumber. Around the world, millions of doses of COVID-19 vaccines have begun arriving through the COVAX Facility in the largest and most rapid g…

Monique Barbut, Hassatou N’Sele and Ingrid van Wees to join IFFIm Board of Directors
01 Jul 2021
New Board members bring diverse backgrounds in global development and finance
London, 1 July 2021 – IFFIm, the International Finance Facility for Immunisation, has appointed three new global development and finance executives to its Board of Directors.  Monique Barbut, President of World Wildlife Fund (WWF) France, Hassatou Diop N’Sele, Treasurer…

 

IFRC [to 17 Jul 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
IFRC warns only way to win race against variants is to boost vaccinations and protection measures
eneva, 16 July 2021 – The International Federation of Red Cross and Red Crescent Societies (IFRC) warns that the global vaccination rate must increase rapidly and protection measures upheld, if we are to win the race against more transmissible, and potentially more deadly, variants.

At least three quarters of people in most countries want to be vaccinated worldwide, in the face of emerging new variants, according to new survey data.1 However, despite lofty rhetoric about global solidarity, there is a deadly gap in the global plan to equitably distribute COVID-19 vaccines. Only around a quarter of the world’s population have received at least one dose of the vaccine. This number drops dramatically in low-income countries, where only 1% of people have received one dose.2 And some countries are yet to start mass vaccination campaigns.

Jagan Chapagain, Secretary General of the IFRC, said: “To world leaders we say, it is time to pull out all the stops to boost vaccine production. This includes a temporary waiver on intellectual property, as well as the sharing of knowledge and technology between countries. Vaccine equity is key to reducing the likelihood of variants and saving lives by limiting the spread of the virus. This is the only way we can truly end this pandemic.

“The IFRC is already playing its part to get vaccines into the arms of the most vulnerable, but in some countries, vaccination campaigns have hardly started. Our data shows that people want to be vaccinated, but production and vaccine dose sharing needs to happen much faster if we want vaccination to outpace the variants.”…

Asia Pacific, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Thailand, Vietnam
South East Asia: COVID-19 vaccine divide widens as Delta surges
Kuala Lumpur/Jakarta/Geneva, 13 July 2021: A deadly wave of COVID-19 fuelled by the Delta variant is crashing into South East Asia as the International Federation of Red Cross and Red Crescent Societies warns of a widening global vaccine divide. Countr …
13 July 2021

 

Institut Pasteur [to 17 Jul 2021]
https://www.pasteur.fr/en/press-area
Press Documents
No new digest content identified.

 

IOM / International Organization for Migration [to 17 Jul 2021]
http://www.iom.int/press-room/press-releases
News
IOM Provides Over 1,300 Migrants with Emergency Shelter and Assistance on the Canary Islands
2021-07-16 10:45
Madrid – As more migrants arrive in the Canary Islands, the International Organization for Migration (IOM) has provided shelter, protection services, medical, legal and other types of assistance to 1,361 migrants on Tenerife.

IOM Ethiopia Appeals for USD 40 Million to Assist Additional 1.6 Million People in Northern Ethiopia
2021-07-16 10:45
Addis Ababa – Nearly two million people affected by the crisis in northern Ethiopia desperately need life-saving assistance, including water, medicine and shelter, the International Organization for Migration (IOM) said today as it issued an urgent appeal for USD 40 million to…

Deaths on Maritime Migration Routes to Europe Soar in First Half of 2021: IOM Brief
2021-07-13 23:54
Berlin – At least 1,146 people died attempting to reach Europe by sea in the first six months of 2021 according to a new briefing released today by the International Organization for Migration (IOM).

Dominican Republic and IOM Help Clear Hurdles for 100,000 Venezuelan Migrants
2021-07-13 13:57
Santo Domingo – The first group of almost 100,000 Venezuelan migrants without legal status in the Dominican Republic have received visas allowing them to work, open bank accounts and join the social security system under the country’s Migration Normalization Plan.

 

IVAC [to 17 Jul 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
Webinar: Preventing the Next Pandemic: Vaccine Diplomacy, Surveillance and COVID Vaccines
When: Jul 30, 2021 at 11:00 AM Eastern Time
Description: Join Dr. Peter Hotez for a 60-minute webinar hosted by the International Vaccine Access Center to discuss topics ranging from vaccine diplomacy, the antivaccine movement, safety surveillance, and a new COVID vaccine.

 

IVI [to 17 Jul 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
IVI welcomes Bangladesh as state party with ratification ceremony
July 15, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) hosted a ceremony at headquarters today honoring the People’s Republic of Bangladesh’s ratification of the IVI Establishment Agreement. Over 20 years of vaccine research and capacity-building initiatives with partners in Bangladesh have led to significant achievements in global public health, including the domestic development and delivery of IVI’s oral cholera vaccine, and IVI officially welcomes Bangladesh as its 19th state party.

 

JEE Alliance [to 17 Jul 2021]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

Johns Hopkins Center for Health Security [to 17 Jul 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
Johns Hopkins Center for Health Security Commends the Interacademy Partnership for Endorsing Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists
July 14, 2021
Wednesday, July 14, 2021 – Advances in the biological sciences bring about wellbeing for humanity, but the same advances could be misused, particularly for the development and proliferation of biological weapons.
Since January 2021, the Johns Hopkins Center for Health Security has worked with Tianjin University, the Interacademy Partnership, with support from the US Department of State and the Chinese Ministry of Foreign Affairs to develop the Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists. The Codes of Conduct outline a set of guiding principles and standards of conduct for all involved in the biological sciences to guard against the misuse of biology and the development of biological weapons. The Tianjian Biosecurity Guidelines will help to prevent misuse of bioscience research without hindering beneficial outcomes, in accordance with the articles and norms of the Biological and Toxin Weapons Convention, and in advancement of progress towards achieving the UN Sustainable Development Goals.
:: Read the Tianjin Biosecurity Guidelines for Codes of Conduct for Scientists.
New Report: Carrying Equity in COVID-19 Vaccination Forward: Guidance Informed by Communities of Color
July 14, 2021

 

MSF/Médecins Sans Frontières [to 17 Jul 2021]
http://www.msf.org/
Latest [Selected Announcements]
South Sudan
South Sudan: 10 years of independence, violence, disease and dire needs
Project Update 16 Jul 2021

Somalia
Increasing vaccination against measles in Lower Juba could prevent thousands of deaths
Project Update 14 Jul 2021

 

National Academy of Medicine – USA [to 17 Jul 2021]
https://nam.edu/programs/
Selected News/Programs
No new digest content identified.

 

National Vaccine Program Office – U.S. HHS [to 17 Jul 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.

 

NIH [to 17 Jul 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIH-funded study finds gene therapy may restore missing enzyme in rare disease
July 16, 2021 — Results provide hope for children with aromatic L-amino acid decarboxylase deficiency.

 

PATH [to 17 Jul 2021]
https://www.path.org/media-center/
Press Releases
PATH and Quansys Biosciences launch Q-Plex™ Human Environmental Enteric Dysfunction Diagnostic (11-Plex) to accelerate EED interventions
Effective and affordable new research diagnostic tool can measure up to 11 key biomarkers of environmental enteric dysfunction with a single test
July 14, 2021

New partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide
The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria.
July 14, 2021

 

Sabin Vaccine Institute [to 17 Jul 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 17 Jul 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
12 July 2021
UNAIDS saddened by the death of Geoff Makhubo, Executive Mayor of Johannesburg

 

UNHCR Office of the United Nations High Commissioner for Refugees [to 17 Jul 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
Attacks by armed group displace 20,000 civilians in eastern DRC
16 Jul 2021

 

 

News comment: UNHCR latest update on deteriorating situation of Eritrean refugees in Tigray
This news comment is attributable to Ann Encontre, UNHCR Representative in Ethiopia
15 Jul 2021

 

 

Statement by UN High Commissioner for Refugees Filippo Grandi on the situation of Eritrean refugees in Ethiopia’s Tigray Region
13 Jul 2021

 

 

UNHCR warns of imminent humanitarian crisis in Afghanistan
13 Jul 2021

 

UNICEF [to 17 Jul 2021]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Statement
07/15/2021
Syria: Up to 1 million people at risk due to severe interruptions to Alouk Water Station
Joint statement by United Nations Resident Coordinator and Humanitarian Coordinator for Syria, Imran Riza, Regional Humanitarian Coordinator for the Syria Crisis, Muhannad Hadi and UNICEF Regional Director for the Middle East and North Africa, Ted Chaiban

Press release
07/15/2021
COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows
23 million children missed out on basic childhood vaccines through routine health services in 2020, the highest number since 2009 and 3.7 million more than in 2019
[See COVID above for detail]

Statement
07/14/2021
Statement on the arrival of the first batch of COVID-19 vaccines in Haiti
Statement by Jean Gough, UNICEF Regional Director for Latin America and the Caribbean

Press release
07/14/2021
Nearly 40 per cent of young people on the move identify education and training as top priorities, according to new UNICEF poll

Press release
07/13/2021
1 in 3 countries are not taking action to help students catch up on their learning post-COVID-19 school closures
A new UNESCO, UNICEF, World Bank and OECD report documents education responses to COVID-19 in 142 countries

Statement
07/13/2021
Message from UNICEF Executive Director Henrietta Fore to staff

News note
07/12/2021
UNICEF signs supply agreement for Sinopharm COVID-19 vaccine
[See COVID above for detail]

Remarks
07/12/2021
UNICEF Executive Director Henrietta Fore’s remarks at the launch of the State of Food Security and Nutrition in the World report 2021

Press release
07/12/2021
UN report: Pandemic year marked by spike in world hunger
Africa posting biggest jump. World at critical juncture, must act now for 2030 turnaround

 

Unitaid [to 17 Jul 2021]
https://unitaid.org/
Featured News
15 July 2021
FIND and Unitaid invest to support technology transfer and boost local production of COVID-19 rapid tests in low- and middle-income countries
Technology transfer agreements signed to enable expanded production of high-quality antigen rapid tests in Africa and Latin America
Agreements signed with DCN Dx to transfer know-how to WAMA Diagnóstica (Brazil), and Bionote and Mologic to transfer know-how to DIATROPIX of the Institut Pasteur de Dakar (Senegal)
Separate partnership between Viatris (South Africa) and Guangzhou Wondfo Biotech (China) supported to enable commercialization and distribution of high-quality Ag RDTs in low- and middle-income countries
Agreements follow open call launched last year by FIND and Unitaid on behalf of the Access to COVID-19 Tools (ACT) Accelerator, to drive equitable access to rapid tests for COVID-19

14 July 2021
New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide
The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals.
PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria.

Vaccine Equity Initiative [to 17 Jul 2021]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.

 

Vaccination Acceptance & Demand Initiative [Sabin) [to 17 Jul 2021]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 17 Jul 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 17 Jul 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.

 

Wellcome Trust [to 17 Jul 2021]
https://wellcome.ac.uk/news
News and reports
No new digest content identified.

 

The Wistar Institute [to 17 Jul 2021]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

 

WFPHA: World Federation of Public Health Associations [to 17 Jul 2021]
https://www.wfpha.org/
Latest News
No new digest content identified.

 

World Bank [to 17 Jul 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
African Heads of State Call for an Ambitious Replenishment of the IDA20 to Support Their Recovery Agenda
ABIDJAN, July 15, 2021 – Thirteen African Heads of State and governments concluded their one-day meeting in Abidjan today with a strong resolution to accelerate economic…
Date: July 15, 2021 Type: Press Release

Statement July 15, 2021
Abidjan’s Declaration
Following the Meeting of Heads of State and Government of Angola, Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Guinea Bissau, Kenya, Liberia, Madagascar, Mauritania, Mozambique, Niger, Nigeria, Uganda, Rwanda, Senegal, Sudan, Tanzania and Togo to Support A Twentieth (20th) Ambitious Replenishment of the Resources of the International Development Association (IDA20)

Food Security and COVID-19
July 16, 2021 — An increasing number of countries are facing growing levels of acute food insecurity, reversing years of development gains. Even before COVID-19 reduced incomes and disrupted supply chains…
Date: July 14, 2021 Type: Brief

Africa’s Scientific Solutions and Innovation in the Fight Against COVID-19
Challenge Increased productivity, economic diversification, and structural reforms across Africa will require the strategic production and retention of many highly skilled and employable graduates, particularly…
Date: July 14, 2021 Type: Result Brief

1 in 3 countries are not taking action to help students catch up on their learning post-COVID-19 school closures
A new UNESCO, UNICEF, World Bank and OECD Report documents education responses to COVID-19 in 142 countries
Date: July 13, 2021 Type: Press Release

Remarks by World Bank Group President David Malpass at the G20 Session on International Financial Architecture – Lead Intervention
VENICE, July 9, 2021 – Good afternoon.  The recovery from the COVID-19 pandemic will require huge resources and coordination among development partners.  Early in the pandemic, the World Bank…
Date: July 09, 2021 Type: Speeches and Transcripts

 

World Customs Organization – WCO [to 17 Jul 2021]
http://www.wcoomd.org/
Latest News – Selected Items
14 July 2021
Joint Indicative List of Critical COVID-19 Vaccine Inputs issued by the joint effort of WCO/WTO and other organizations

 

World Organisation for Animal Health (OIE) [to 17 Jul 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases, Statements
Bridging partnerships towards the global control of African swine fever
News
12 July 2021
In the context of the global initiative for the control of African swine fever (ASF) launched in 2020, the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (OIE) have committed to create a forum of discussion between the public and the private sectors to discuss the latest findings and ways forward to control this deadly animal disease.

 

WTO – World Trade Organisation [to 17 Jul 2021]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
WTO issues joint indicative list of critical inputs for COVID-19 vaccines
13 July 2021
The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines. The list was jointly produced with the Asian Development Bank, the Organisation for Economic Cooperation and Development, the World Customs Organization, some COVID-19 vaccine manufacturers, researchers Chad Bown and Chris Rogers, the Coalition for Epidemic Preparedness Innovations and DHL.

WTO holds two-day workshop on SPS risk analysis
13 July 2021
The WTO held on 12-13 July a virtual Workshop on Risk Assessment, Risk Management and Risk Communication in relation to food safety, animal and plant health. With over 1,000 registered participants, the workshop brought together a variety of speakers from the public and private sector, academia, international standard-setting bodies and other international organizations for an in-depth discussion on all aspects of sanitary and phytosanitary (SPS) risk analysis.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 17 Jul 2021]
Press Releases – Alliance for Regenerative Medicine (alliancerm.org)
Selected Press Releases
No new digest content identified.

 

BIO [to 17 Jul 2021]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 17 Jul 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 17 Jul 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.

 

IFPMA [to 17 Jul 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
COVAX launches Marketplace to match buyers and sellers of critical manufacturing suppliers and speed up
15 July 2021 – IFPMA welcomes the launch of an innovative ‘marketplace’. The new Marketplace aims to accelerate the global production of COVID-19 vaccine doses for COVAX by matching suppliers of critical inputs with vaccine manufacturers who urgently need them to produce vaccines for fair and equitable distribution through COVAX. This initiative spearheaded by Coalition for Epidemic Preparedness Innovations (CEPI) is a key deliverable of the COVAX Manufacturing Task Force, which is co-led by COVAX and industry partners[1]

 

International Alliance of Patients’ Organizations – IAPO [to 17 Jul 2021]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.

 

PhRMA [to 17 Jul 202
http://www.phrma.org/
Latest News [Selected]
Promoting global vaccine equity while protecting innovation
July 15, 2021
The transformative promise of COVID-19 vaccines only extends as far as patients’ ability to access them. Equitable distribution worldwide is critical. Despite significant cross-sector and multi-stakeholder efforts like COVAX, we are still seeing vaccine access and distribution challenges across many regions of the world due to complex barriers.
Blog Post

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Transgenerational Trauma

AMA Journal of Ethics
Volume 23, Number 6: E435-504 June 2021
https://journalofethics.ama-assn.org/issue/transgenerational-trauma

 

Transgenerational Trauma
One thing that makes trauma transgenerational is narrative. Narrative, for example, is what makes a Confederate flag from 1865 flint for insurrection in 2021. Consequences of global and domestic insults, such as slavery and forced migration, have long ramified intergenerationally in communities, families, and individuals’ bodies. Legacies of trauma travel in stories across places and over time, and their effects include health status inequity and cumulative stress embodiment. Transmission of historically entrenched patterns of oppression also influence persons’ lived experiences of marginalization, convey health risk, and can play out during clinical encounters.

Social dynamics of a population-level dashboard for antimicrobial stewardship: A qualitative analysis

American Journal of Infection Control
July 2021 Volume 49 Issue 7 p857-972
http://www.ajicjournal.org/current

 

Major Articles
Social dynamics of a population-level dashboard for antimicrobial stewardship: A qualitative analysis
Peter Taber, Charlene Weir, Jorie M. Butler, … Matthew H. Samore, Matthew Bidwell Goetz, Peter A. Glassman
Published online: January 27, 2021
p862-867

Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors

American Journal of Preventive Medicine
July 2021 Volume 61 Issue 1 p1-148
http://www.ajpmonline.org/current

 

Research Articles
Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors
Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk,…Lee H. Harrison, William Schaffner, Richard K. Zimmerman
Published online: April 29, 2021
p28-36

Easing Human Papillomavirus Vaccine Hesitancy: A Communication Experiment With U.S. Parents

American Journal of Preventive Medicine
July 2021 Volume 61 Issue 1 p1-148
http://www.ajpmonline.org/current

 

Easing Human Papillomavirus Vaccine Hesitancy: A Communication Experiment With U.S. Parents
Parth D. Shah, William A. Calo, Melissa B. Gilkey,…Susan Alton Dailey, Karen G. Todd, Noel T. Brewer
Published online: May 08, 2021
p88-95
Published online: May 18, 2021
p105-114

The CORBEL matrix on informed consent in clinical studies: a multidisciplinary approach of Research Infrastructures Building Enduring Life-science Services

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 17 Jul 2021)

 

The CORBEL matrix on informed consent in clinical studies: a multidisciplinary approach of Research Infrastructures Building Enduring Life-science Services
Informed consent forms for clinical research are several and variable at international, national and local levels. According to the literature, they are often unclear and poorly understood by participants. Wit…
Authors: Cinzia Colombo, Michaela Th. Mayrhofer, Christine Kubiak, Serena Battaglia, Mihaela Matei, Marialuisa Lavitrano, Sara Casati, Victoria Chico, Irene Schluender, Tamara Carapina and Paola Mosconi
Citation: BMC Medical Ethics 2021 22:95
Content type: Research article
Published on: 17 July 2021

Consent to research participation: understanding and motivation among German pupils

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 17 Jul 2021)

 

Consent to research participation: understanding and motivation among German pupils
The EU’s 2006 Paediatric Regulation aims to support authorisation of medicine for children, thus effectively increasing paediatric research. It is ethically imperative to simultaneously establish procedures th…
Authors: Jana Reetz, Gesine Richter, Christoph Borzikowsky, Christine Glinicke, Stephanie Darabaneanu and Alena Buyx
Citation: BMC Medical Ethics 2021 22:93
Content type: Research article
Published on: 16 July 2021

Consent to research participation: understanding and motivation among German pupils

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 17 Jul 2021)

 

Consent to research participation: understanding and motivation among German pupils
The EU’s 2006 Paediatric Regulation aims to support authorisation of medicine for children, thus effectively increasing paediatric research. It is ethically imperative to simultaneously establish procedures th…
Authors: Jana Reetz, Gesine Richter, Christoph Borzikowsky, Christine Glinicke, Stephanie Darabaneanu and Alena Buyx
Citation: BMC Medical Ethics 2021 22:93
Content type: Research article
Published on: 16 July 2021

Influenza vaccination during pregnancy and influencing factors in Korea: A multicenter questionnaire study of pregnant women and obstetrics and gynecology doctors

BMC Pregnancy and Childbirth
http://www.biomedcentral.com/bmcpregnancychildbirth/content
(Accessed 17 Jul 2021)

 

Influenza vaccination during pregnancy and influencing factors in Korea: A multicenter questionnaire study of pregnant women and obstetrics and gynecology doctors
Although the World Health Organization and health authorities in most countries recommend that pregnant women receive inactivated influenza virus vaccines, coverage remains low. This study aimed to investigate…
Authors: Byung Soo Kang, San Ha Lee, Woo Jeng Kim, Jeong Ha Wie, In Yang Park and Hyun Sun Ko
Citation: BMC Pregnancy and Childbirth 2021 21:511
Content type: Research article
Published on: 16 July 2021

Participants communicating online • Community perspectives in Malawi Enrolling Children in Clinical Trials for Genetic Neurodevelopmental Conditions: Ethics, Parental Decisions, and Children’s Identities

Ethics & Human Research
Volume 43, Issue 4 Pages: 1-44 July–August 2021
https://onlinelibrary.wiley.com/toc/25782363/current

 

Participants communicating online • Community perspectives in Malawi
Enrolling Children in Clinical Trials for Genetic Neurodevelopmental Conditions: Ethics, Parental Decisions, and Children’s Identities
Erin Turbitt, Ainsley J. Newson, Barbara B. Biesecker, Benjamin S. Wilfond
Pages: 27-36
First Published: 01 July 2021
Abstract
Knowledge of genetic mechanisms contributing to neurodevelopmental conditions is advancing. This is informing development of new drugs to treat or ameliorate these conditions, through targeting underlying genetic pathways. Drugs are tested in clinical trials, necessitating parents to engage with decisions about whether to enroll their child. In this article, we consider important ethical issues to anticipate as clinical research opportunities in genetic neurodevelopmental conditions arise. For example, genetic pathways targeted by the drugs may interact with valued character and personality traits. It is essential that recruitment and consent processes are optimized for families who will grapple with whether these novel drug treatments interact with their child’s personality and authentic identity. We call for focused social science research and further normative analysis so that parents are better supported to make informed choices. Additionally, clinical research regulators should have a sound understanding of the contextual experiences regarding how this population of parents engages with decisions.

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions

The European Journal of Public Health
SUPPLEMENT – Volume 31, Issue Supplement_1, July 2021
https://academic.oup.com/eurpub/issue/31/Supplement_1

 

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions
Mental illness represents an enormous personal, social and societal burden for European citizens1 calling for the need to expand existing models of mental healthcare delivery. In Europe, the Internet is a key source of health information,2 and technology-enhanced (psychological) interventions such as Internet- and mobile-delivered applications (‘eHealth’3 and ‘m-Health’4) have become increasingly popular and studied. There is already strong evidence of the efficacy of online interventions for the prevention and treatment of several psychological disorders5,6 and meta-analyses show effect sizes similar to face-to-face interventions.7

Using maternal and neonatal data collection systems for coronavirus disease 2019 (COVID-19) vaccines active safety surveillance in low- and middle-income countries: an international modified Delphi study

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 17 Jul 2021]

 

Research Article metrics AWAITING PEER REVIEW
Using maternal and neonatal data collection systems for coronavirus disease 2019 (COVID-19) vaccines active safety surveillance in low- and middle-income countries: an international modified Delphi study [version 1; peer review: awaiting peer review]
Veronica Pingray, María Belizán, Sarah Matthews, Sabra Zaraa, Mabel Berrueta, Lisa M. Noguchi, Xu Xiong, Alejandra Gurtman, Judith Absalon, Jennifer C. Nelson, Lakshmi Panagiotakopoulos, Esperanca Sevene, Flor M. Munoz, Fernando Althabe, Kissa W. Mwamwitwa, Federico Rodriguez Cairoli, Steven A. Anderson, Elizabeth M. McClure, Christine Guillard, Annettee Nakimuli, Andy Stergachis, Pierre Buekens
Peer Reviewers Invited
Funder – Bill and Melinda Gates Foundation
PUBLISHED 12 Jul 2021

An international policy on returning genomic research results

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 17 Jul 2021]

 

An international policy on returning genomic research results
Authors: Anna C. F. Lewis, Bartha Maria Knoppers and Robert C. Green
Citation: Genome Medicine 2021 13:115
Content type: Comment
Published on: 15 July 2021
Abstract
The Global Alliance for Genomics and Health has approved a policy for the return of clinically actionable genomic research results, the first such policy approved by an international body. The policy acknowledges the potential medical benefits to millions of individuals who are participating in genomics research. It ties the pace of implementation to each country’s clinical standards, including for the return of secondary findings, and urges funders to set aside resources to support responsible return.

Israel: Family Court Authorizes Vaccination of Minors Without Father’s Consent

Global Legal Monitor – Library of Congress/USA
https://www.loc.gov/collections/global-legal-monitor/
[Accessed 17 Jul 2021]

 

Article
Israel: Family Court Authorizes Vaccination of Minors Without Father’s Consent
In a decision rendered on July 1, 2021, the Haifa Family Court president, Judge Shelly Eisenberg, authorized a mother to vaccinate her two 15-year-old minors against the coronavirus despite their father’s objection.According to the mother, the Ministry of Health had encouraged vaccination of minors ages 12–15 in view of the rise in infections in this … Continue reading “Israel: Family Court Authorizes Vaccination of…
Contributor: Levush, Ruth
Date: 2021-07-13

July 2021 | Borders, Immigrants & Health

Health Affairs
Vol. 40, No. 7 July 2021
https://www.healthaffairs.org/toc/hlthaff/current

 

July 2021 | Borders, Immigrants & Health
About one in seven residents of the US is an immigrant, and about fifteen million people live within 100 kilometers of the US-Mexico border. Disparities in health status exist between people born in the US and those who have immigrated. Immigration policy has been contentious throughout US history, and current policies in the US and Mexico have significant effects on the health and well-being of tens of millions of people. This thematic issue of Health Affairs focuses on immigrants and borders. The overview article by Arturo Vargas Bustamante and coauthors describes a range of health policy issues raised by the continuously shifting demography of US immigrants.

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar

JAMA
July 6, 2021, Vol 326, No. 1, Pages 11-96
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar
Roberto Bertollini, MD, MPH; Hiam Chemaitelly, MSc; Hadi M. Yassine, PhD; et al.
free access has active quiz
JAMA. 2021;326(2):185-188. doi:10.1001/jama.2021.9970
This study explores the association of vaccination against COVID-19 or prior SARS-CoV-2 infection with PCR test positivity in airline passengers arriving in Qatar, February-April 2021.

COVID-19 Vaccination of Minors Without Parental ConsentRespecting Emerging Autonomy and Advancing Public Health

JAMA Pediatrics
July 2021, Vol 175, No. 7, Pages 663-756
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

July 12, 2021
Viewpoint online First
COVID-19 Vaccination of Minors Without Parental ConsentRespecting Emerging Autonomy and Advancing Public Health
Larissa Morgan, JD, MBE; Jason L. Schwartz, PhD; Dominic A. Sisti, PhD
free access
JAMA Pediatr. Published online July 12, 2021. doi:10.1001/jamapediatrics.2021.1855
This Viewpoint discusses allowing minors to consent and receive the COVID-19 vaccine without parental authorization.

Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 YearsA Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies

JAMA Pediatrics
July 2021, Vol 175, No. 7, Pages 663-756
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Original Investigation
Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 YearsA Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies
Zi-Wei Sun, MSc; Yu Fu, BS; Hai-Ling Lu, MD; et al.
online only
JAMA Pediatr. 2021;175(7):e210347. doi:10.1001/jamapediatrics.2021.0347
This meta-analysis synthesizes randomized clinical trials and observational studies to evaluate the comparative benefit, risk, and immunogenicity of different rotavirus vaccines.

Overview of the Issue

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Influenza Vaccine Failure Associated With Age and Immunosuppression

Journal of Infectious Diseases
Volume 224, Issue 2, 15 July 2021
https://academic.oup.com/jid/issue/224/2

 

VIRUSES
Influenza Vaccine Failure Associated With Age and Immunosuppression
Joanna Kimball, Yuwei Zhu, Dayna Wyatt, Christopher H Trabue, H Keipp Talbot
The Journal of Infectious Diseases, Volume 224, Issue 2, 15 July 2021, Pages 288–293, https://doi.org/10.1093/infdis/jiaa757
Vaccine failure continues to be a challenge in our efforts to prevent influenza illnesses and hospitalizations. When evaluating influenza-vaccinated patients hospitalized with an influenza-like illness, older and immunosuppressed patients were found to be at increased risk for hospitalization with influenza.

Development of a structured process for fair allocation of critical care resources in the setting of insufficient capacity: a discussion paper

Journal of Medical Ethics
July 2021 – Volume 47 – 7
http://jme.bmj.com/content/current

 

Development of a structured process for fair allocation of critical care resources in the setting of insufficient capacity: a discussion paper (20 November, 2020) Free
Tim Cook, Kim Gupta, Chris Dyer, Robin Fackrell, Sarah Wexler, Heather Boyes, Ben Colleypriest, Richard Graham, Helen Meehan, Sarah Merritt, Derek Robinson, Bernie Marden

Public involvement in the governance of population-level biomedical research: unresolved questions and future directions (6 October, 2020)

Journal of Medical Ethics
July 2021 – Volume 47 – 7
http://jme.bmj.com/content/current

 

Brief reports
Public involvement in the governance of population-level biomedical research: unresolved questions and future directions (6 October, 2020)
Sonja Erikainen, Phoebe Friesen, Leah Rand, Karin Jongsma, Michael Dunn, Annie Sorbie, Matthew McCoy, Jessica Bell, Michael Burgess, Haidan Chen, Vicky Chico, Sarah Cunningham-Burley, Julie Darbyshire, Rebecca Dawson, Andrew Evans, Nick Fahy, Teresa Finlay, Lucy Frith, Aaron Goldenberg, Lisa Hinton, Nils Hoppe, Nigel Hughes, Barbara Koenig, Sapfo Lignou, Michelle McGowan, Michael Parker, Barbara Prainsack, Mahsa Shabani, Ciara Staunton, Rachel Thompson, Kinga Varnai, Effy Vayena, Oli Williams, Max Williamson, Sarah Chan, Mark Sheehan

Mitigating Ethical Risks in Public-Private Partnerships in Public Health

Journal of Public Health Management & Practice
July/August 2021 – Volume 27 – Issue 4
https://journals.lww.com/jphmp/pages/currenttoc.aspx

 

Research Reports
Mitigating Ethical Risks in Public-Private Partnerships in Public Health
Yassanye, Diana M.; Anason, Andrea P.; Barrett, Drue H.
Journal of Public Health Management and Practice. 27(4):E177-E182, July/August 2021.
Partnerships between the public and private sectors are necessary in public health and health care. Each partner provides skills, resources, and capabilities. When the public sector, including government, enters into a partnership with a nongovernmental or corporate entity, it is important to determine in advance whether there are real or perceived ethical, financial, or programmatic risks to the organization that might need mitigation.

COVID-19 in Africa: a lesson in solidarity

The Lancet
Jul 17, 2021 Volume 398 Number 10296 p185-276, e7
https://www.thelancet.com/journals/lancet/issue/current

 

Editorial
COVID-19 in Africa: a lesson in solidarity
The Lancet
Many countries in Africa face a serious third wave of COVID-19 that is both larger and more burdensome on health systems than previous waves. This predictable turn of events has been driven by a morally reprehensible lack of vaccine equity (<1% of the population are fully vaccinated), leaving the continent vulnerable to new and more transmissible variants of the virus, behavioural and economic pandemic fatigue, and complacency. A lack of diagnostic capacity in some countries means the epidemiology of this current wave is uncertain, but South Africa, Namibia, and Zambia are reporting the highest numbers of new cases. The Delta variant has been detected in more than 14 countries across the region and pathogen genomic monitoring in South Africa shows that it is quickly becoming the dominant variant there. Unless vaccines are rolled out quickly there will be subsequent waves of infection. But in the face of adversity, the African health community continues to work collaboratively, balancing short-term needs and long-term health security plans, and creating grounds for hope. Collaboration and solidarity are prerequisites for success in a pandemic. Unfortunately, beyond scientific discovery, they have rarely been displayed globally. A new report from Chatham House explores the concept of solidarity in response to COVID-19. It highlights that international, regional, and within-country solidarity has been poor, but commends the alliance between the Africa Centres for Disease Control and Prevention, the African Union, and the WHO Regional Office for Africa in galvanising cooperation in the region. Together, this alliance has launched initiatives ranging from the Africa Medical Supplies Platform, which pools orders for medical supplies, to the Africa Vaccine Delivery Alliance, which aims to organise vaccine roll-out plans. Rarely for COVID-19 response leadership, women occupy key positions in these organisations. This progressive unity has been driven by local scientists and the health community and should be fully engaged with and amplified by all politicians of African Union member states.

One of the most promising results of this partnership is the acquisition of 400 million doses of the Johnson & Johnson single-dose vaccine before the end of 2022. African Union member states can purchase the vaccine through a pooled procurement mechanism. When these vaccines will arrive is uncertain, and supply chains might slow delivery. But in theory, the deal should give countries a predictable supply of vaccine.

Implementation of vaccination programmes, though, is a challenge. 60% of countries with an extreme shortage of health-care workers are found in Africa. The continent has a population of 74 million people older than 60 years (of a total population of 1·3 billion), and many people who might be considered at high risk from COVID-19 because of comorbidities might be unaware, so prioritising groups for vaccination will need to be done locally. Although the vaccine doses themselves are funded, it is unclear how getting vaccines into people’s arms will be financed. It is estimated that for every US$1 spent on a COVID-19 vaccine dose, $5 is needed for delivery. Even if the supply of Johnson & Johnson vaccine materialises in the coming months, vaccines are needed now. The need to vaccinate large proportions of the population while health systems strain under a third wave could have been avoided had international dissonance and vaccine nationalism not left African countries at the back of the vaccine queue. Nevertheless, the Johnson & Johnson vaccine should cover 30% of the population, COVAX should supply enough doses to cover 30% more, and, with additional bilateral agreements, more than 60% vaccine coverage can be achieved. These achievements in negotiating and organising this arrangement beg the question, why were African health leaders not more involved in the construction of COVAX?

There is a serious need and desire for Africa to take control of its own health security, so that countries can shape their future health. There is an ambitious drive for each country to have its own public health institution, supported by a centralised Africa Centres for Disease Control and Prevention, and a plan for the continent to manufacture its own vaccines, therapeutics, and diagnostics, with the public health workforce expanded to act as an epidemic response service.

The regional solidarity on display by many within the African health community has been impressive but can only go so far when international solidarity remains so derisory. A reckoning must be had over how the multilateral system approaches Africa, with a promise that no global health initiative, foundation, or organisation is governed without involvement from African health leaders at every decision-making level.

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

The Lancet
Jul 17, 2021 Volume 398 Number 10296 p185-276, e7
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Mine Durusu Tanriover, et al. and the CoronaVac Study Group

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

Lancet Global Health
Jul 2021 Volume 9 Number 7 e880-e1027
https://www.thelancet.com/journals/langlo/issue/current

 

Articles
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
Frédéric Debellut, et al

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Lancet Global Health
Jul 2021 Volume 9 Number 7 e880-e1027
https://www.thelancet.com/journals/langlo/issue/current

 

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies
Naor Bar-Zeev, et al for the VacSurv Consortium

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

Lancet Infectious Diseases
Jul 2021 Volume 21 Number 7 p889-1050, e182-e207
https://www.thelancet.com/journals/laninf/issue/current

 

Articles
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, et al.